BioSpace News Archive

Genetown

Apellis Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 1:20 p.m. ET.

June 4, 2020
·
1 min read
BioMidwest

Myriad Genetics Announces Publication of a Prospective Clinical Study of the EndoPredict® Test in Women with Early-Stage Breast CancerEndoPredict Predicts Response to Neoadjuvant Chemotherapy and Endocrine Therapy

Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced the publication of a prospective study demonstrating that the EndoPredict® test predicts which patients with ER+, HER2- early-stage breast cancer will benefit from neoadjuvant therapy.

June 4, 2020
·
8 min read
Pharm Country

Axsome Therapeutics to Present at Upcoming Investor Conferences in June 2020

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, will participate in two upcoming investor conferences

June 4, 2020
·
4 min read
Pharm Country

Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Amicus Therapeutics announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference, being held virtually on Wednesday, June 10, 2020 at 8:00 a.m. ET.

June 4, 2020
·
1 min read
Business

Prevail Therapeutics Appoints Kira Schwartz, J.D., as General CounselMs. Schwartz brings over 16 years of legal experience in the biopharma industry to Prevail’s leadership team

Prevail Therapeutics Inc., a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, announced the appointment of Kira Schwartz, J.D., as the Company’s General Counsel.

June 4, 2020
·
2 min read
Business

Apexigen Appoints Gordon Ringold to its Board of Directors

Apexigen, Inc. announced the appointment of Gordon Ringold, Ph.D., to its Board of Directors.

June 4, 2020
·
2 min read
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment

Recently announced clinical data demonstrate pelareorep-induced priming of an adaptive immune response

June 4, 2020
·
9 min read
Policy

FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., announced that it has received 510 clearance from the U.S. Food and Drug Administration for BAUSCH + LOMB INFUSE™ daily disposable silicone hydrogel contact lenses.

June 4, 2020
·
3 min read
Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

Hollister Biosciences Inc. (CSE: HOLL) (OTCPINK: HSTRF) (Frankfurt: HOB) (the " Company ", " Hollister Cannabis Co .” or " Hollister ") a diversified cannabis branding company with products in over 220 dispensaries throughout California , is pleased to announce that the Company’s 100% owned subsidiary, Al

June 4, 2020
·
3 min read
Drug Development

IRLAB’s Phase IIb/III Study in Parkinson’s disease to Target Good ON

IRLAB’s clinical Phase IIb/III study with the drug candidate mesdopetam in development for the treatment of levodopa induced dyskinesia in Parkinson’s disease, will have a study design with the following main points

June 4, 2020
·
3 min read